Microbial pathogenesis in cystic fibrosis:: Pulmonary clearance of mucoid Pseudomonas aeruginosa and inflammation in a mouse model of repeated respiratory challenge

被引:69
作者
Yu, H
Hanes, M
Chrisp, CE
Boucher, JC
Deretic, V
机构
[1] Univ Michigan, Sch Med, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Sch Med, Unit Lab Anim Med, Ann Arbor, MI 48109 USA
[3] Univ Texas, Hlth Sci Ctr, Lab Anim Resources, San Antonio, TX 78284 USA
关键词
D O I
10.1128/IAI.66.1.280-288.1998
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Chronic endobronchiolitis compounded by recurring Pseudomonas aeruginosa infections is the major cause of morbidity and mortality in patients with cystic fibrosis (CE), In this study, a mouse model of repeated respiratory exposure to P. aeruginosa was established to facilitate investigations of factors contributing to P. aeruginosa persistence and associated inflammatory processes in the lung, While a single exposure to P. aeruginosa aerosols resulted in only mild histopathological changes, repeated exposure caused significant lung pathology in C57BL/6J mice. The peak of histopathological changes and inflammation in C57BW/6J mice was characterized by subacute lymphohistiocytic bronchopneumonia and persistent elevation of turner necrosis factor alpha and macrophage inflammatory protein 2 in the lung but not in the serum, When isogenic nonmucoid (mucA(+)) and mucoid (mucA22) P. aeruginosa strains were compared, the mucoid cells were cleared several-fold less efficiently than the parental nonmucoid strain during the initial stages of the aerosol exposure regimen. However, the microscopic pathology findings and proinflammatory cytokine levels were similar in mice exposed to nonmucoid and mucoid P. aeruginosa throughout the infection. We also tested lung histopathology and proinflammatory cytokines in interleukin 10 (IL-10)-deficient transgenic (IL-1OT) mice. Significant mortality was seen in IL-1OT mice on initial challenge with P. aeruginosa, although no histopathological differences could be observed in the lungs of C57BL/6J and surviving IL-1OT mice after a single exposure, However, increased pathology was detected in IL-1OT mice relative to C57BL/6J after repeated challenge with P. aeruginosa. This observation supports the proposals that anti-inflammatory cytokines may play a role in suppressing P. aeruginosa-induced tissue damage during chronic infection.
引用
收藏
页码:280 / 288
页数:9
相关论文
共 55 条
[1]   AUXOTROPHIC VARIANTS OF PSEUDOMONAS-AERUGINOSA ARE SELECTED FROM PROTOTROPHIC WILD-TYPE STRAINS IN RESPIRATORY-INFECTIONS IN PATIENTS WITH CYSTIC-FIBROSIS [J].
BARTH, AL ;
PITT, TL .
JOURNAL OF CLINICAL MICROBIOLOGY, 1995, 33 (01) :37-40
[2]   FUNCTIONAL-ROLE OF MUCOID EXOPOLYSACCHARIDE (ALGINATE) IN ANTIBIOTIC-INDUCED AND POLYMORPHONUCLEAR LEUKOCYTE-MEDIATED KILLING OF PSEUDOMONAS-AERUGINOSA [J].
BAYER, AS ;
SPEERT, DP ;
PARK, S ;
TU, J ;
WITT, M ;
NAST, CC ;
NORMAN, DC .
INFECTION AND IMMUNITY, 1991, 59 (01) :302-308
[3]  
BERMUDEZ LEM, 1988, J IMMUNOL, V140, P3006
[4]  
BIWERSI J, 1994, CYSTIC FIBROSIS CURR, V2, P155
[5]   INFLUENCE OF MUCOID COATING ON CLEARANCE OF PSEUDOMONAS-AERUGINOSA FROM LUNGS [J].
BLACKWOOD, LL ;
PENNINGTON, JE .
INFECTION AND IMMUNITY, 1981, 32 (02) :443-448
[6]   INFLAMMATORY CYTOKINES IN CYSTIC-FIBROSIS LUNGS [J].
BONFIELD, TL ;
PANUSKA, JR ;
KONSTAN, MW ;
HILLIARD, KA ;
HILLIARD, JB ;
GHNAIM, H ;
BERGER, M .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1995, 152 (06) :2111-2118
[7]   Mucoid Pseudomonas aeruginosa in cystic fibrosis: Characterization of muc mutations in clinical isolates and analysis of clearance in a mouse model of respiratory infection [J].
Boucher, JC ;
Mudd, HYMH ;
Deretic, V .
INFECTION AND IMMUNITY, 1997, 65 (09) :3838-3846
[8]  
CASH HA, 1979, AM REV RESPIR DIS, V119, P453
[9]   CYSTIC-FIBROSIS - MOLECULAR-BIOLOGY AND THERAPEUTIC IMPLICATIONS [J].
COLLINS, FS .
SCIENCE, 1992, 256 (5058) :774-779
[10]   SIMPLE-MODEL FOR THE STUDY OF PSEUDOMONAS-AERUGINOSA INFECTIONS IN LEUKOPENIC MICE [J].
CRYZ, SJ ;
FURER, E ;
GERMANIER, R .
INFECTION AND IMMUNITY, 1983, 39 (03) :1067-1071